A PYMNTS Company

Brazilian Watchdog Stops Hapvida’s Healthcare Deal

By  |  November 25, 2021

Brazilian antitrust watchdog CADE has blocked a deal announced by healthcare company Hapvida Participações to by health insurer Plamed.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    CADE´s technical body had given an earlier approval to the deal demanding the sale of part of its 26,000 clients portfolio, but the councillors voted to bar the deal completely. In a securities filing late on Wednesday, the company said it was discussing with its advisors the alternatives for the deal.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.